Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
19
pubmed:dateCreated
2009-9-14
pubmed:abstractText
A series of benzo[d]isothiazole-1,1-dioxides were designed and evaluated as inhibitors of HCV polymerase NS5B. Structure-based design led to the incorporation of a high affinity methyl sulfonamide group. Structure-activity relationship (SAR) studies of this series revealed analogues with submicromolar potencies in the HCV replicon assay and moderate pharmacokinetic properties. SAR studies combined with structure based drug design focused on the sulfonamide region led to a novel and potent cyclic analogue.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
1464-3405
pubmed:author
pubmed-author:AdjabengGeorgeG, pubmed-author:AlexandrovaLudmilaL, pubmed-author:Ao-IeongGloriaG, pubmed-author:BambergJoe TJT, pubmed-author:BlakeJames FJF, pubmed-author:BrandlMichaelM, pubmed-author:BriggsAndrewA, pubmed-author:ElworthyTodd RTR, pubmed-author:FarrellRobertR, pubmed-author:FellJay BJB, pubmed-author:FischerJohnJ, pubmed-author:HarrisSeth FSF, pubmed-author:HendricksRobert TRT, pubmed-author:HilgenkampRamona KRK, pubmed-author:LarrabeeSusanS, pubmed-author:Le PogamSophieS, pubmed-author:LevequeVincent J PVJ, pubmed-author:LoyEE, pubmed-author:MohrPeterP, pubmed-author:NajeraIsabelI, pubmed-author:RajyaguruSonalS, pubmed-author:RobinsonJohn EJE, pubmed-author:SmithDavid BDB, pubmed-author:SpencerStacey RSR, pubmed-author:StengelPeter JPJ, pubmed-author:SukhtankarSunilS, pubmed-author:WangBeihanB, pubmed-author:WongAprilA, pubmed-author:YeeCalvinC, pubmed-author:de VicenteJavierJ
pubmed:issnType
Electronic
pubmed:day
1
pubmed:volume
19
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
5652-6
pubmed:meshHeading
pubmed:year
2009
pubmed:articleTitle
Non-nucleoside inhibitors of HCV polymerase NS5B. Part 4: structure-based design, synthesis, and biological evaluation of benzo[d]isothiazole-1,1-dioxides.
pubmed:affiliation
Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, CA 94304, USA. javier.devicente@roche.com
pubmed:publicationType
Journal Article